The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Comorbidity of Depression with Physical Disorders: Research and Clinical Implications
Open accessAbstract
Depression is prevalent in patients with physical disorders, particularly in those with severe disorders such as cancer, stroke, and acute coronary syndrome. Depression has an adverse impact on the courses of these diseases that includes poor quality of life, more functional impairments, and a higher mortality rate. Patients with physical disorders are at higher risk of depression. This is particularly true for patients with genetic and epigenetic predictors, environmental vulnerabilities such as past depression, higher disability, and stressful life events. Such patients should be monitored closely. To appropriately manage depression in these patients, comprehensive and integrative care that includes antidepressant treatment (with considerations for adverse effects and drug interactions), treatment of the physical disorder, and collaborative care that consists of disease education, cognitive reframing, and modification of coping style should be provided. The objective of the present review was to present and summarize the prevalence, risk factors, clinical correlates, current pathophysiological aspects including genetics, and treatments for depression comorbid with physical disorders. In particular, we tried to focus on severe physical disorders with high mortality rates, such as cancer, stroke, and acute coronary syndrome, which are highly comorbid with depression. This review will enhance our current understanding of the association between depression and serious medical conditions, which will allow clinicians to develop more advanced and personalized treatment options for these patients in routine clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Lasting epigenetic influence of early-life adversity on the BDNF gene
Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.028 · Cited by 1,273 · cited 1×
“Of the various epigenetic mechanisms, DNA methylation is the best studied because it is regarded as a highly stable epigenetic marker.(52) The increased methylation of gene promoters, including 5-HTTLPR and BDNF, is usually associated with lowered gene function and has been associated with depression in general.”
BackgroundLichtman, J. H., Froelicher, E. S., Blumenthal, J. A., Carney, R. M., Doering, L. V., Frasure-Smith, N., Freedland, K. E., Jaffe, A. S., Leifheit-Limson, E. C., Sheps, D. S., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000019 · Cited by 1,208
Hackett, M. L., & Pickles, K. (2014) · International Journal of Stroke · doi:10.1111/ijs.12357 · Cited by 1,140
Collaborative care for depression and anxiety problems
Archer, J., Bower, P., Gilbody, S., Lovell, K., Richards, D., Gask, L., Dickens, C., & Coventry, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006525.pub2 · Cited by 1,126
Depression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083 · cited 1×
“30).(32) A recent systematic review suggested that mortality is an independent outcome of depression after stroke(33) and a subsequent study of 3,250 stroke patients observed that elevated mortality was associated with depression (hazard ratio [HR]: 1.”
BackgroundAyerbe, L., Ayis, S., Wolfe, C. D. A., & Rudd, A. G. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107664 · Cited by 980
Katon, W., Lin, E. H. B., & Kroenke, K. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.11.005 · Cited by 965 · cited 2×
“Finally, with respect to medical costs and the perception of medical symptoms, a systematic review of 31 studies demonstrated that a significantly higher number of medical symptoms were reported in patients with comorbid depression and chronic physical disorders such as diabetes, pulmonary disease, cardiac disease, an…”
BackgroundPrevalence of depression in survivors of acute myocardial infarction: Review of the evidence
Thombs, B. D., Bass, E. B., Ford, D. E., Stewart, K. J., Tsilidis, K. K., Patel, U., Fauerbach, J. A., Bush, D. E., & Ziegelstein, R. C. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.00269.x · Cited by 841 · cited 1×
“8% of patients with ACS experienced major depression during their hospitalization.(10) The individual rate of depression prevalence in patients with physical disorders is about two- to three-fold higher than in the general population (6.”
BackgroundAnguelova, M., Benkelfat, C., & Turecki, G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001336 · Cited by 421
Interventions for treating depression after stroke
Hackett, M. L., Anderson, C. S., House, A., & Xia, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003437.pub3 · Cited by 387
Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378 · cited 1×
“The increased methylation of gene promoters, including 5-HTTLPR and BDNF, is usually associated with lowered gene function and has been associated with depression in general.(53,54) With respect to physical disorders in general, our research group found that patients with physical disorders are at a higher risk of dep…”
BackgroundCoventry, P., Lovell, K., Dickens, C., Bower, P., Chew-Graham, C., McElvenny, D., Hann, M., Cherrington, A., Garrett, C., Gibbons, C. J., et al. (2015) · BMJ · doi:10.1136/bmj.h638 · Cited by 325
Devlin, A. M., Brain, U., Austin, J., & Oberlander, T. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012201 · Cited by 308 · cited 1×
“The increased methylation of gene promoters, including 5-HTTLPR and BDNF, is usually associated with lowered gene function and has been associated with depression in general.(53,54) With respect to physical disorders in general, our research group found that patients with physical disorders are at a higher risk of dep…”
BackgroundHosang, G. M., Shiles, C., Tansey, K. E., McGuffin, P., & Uher, R. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-7 · Cited by 292
Anguelova, M., Benkelfat, C., & Turecki, G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001328 · Cited by 276
Chochinov, H. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00456-9 · Cited by 271
Sharpe, M., Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., & Murray, G. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61231-9 · Cited by 269
Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., Murray, G., & Sharpe, M. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70343-2 · Cited by 155
The prevalence and pharmacotherapy of depression in cancer patients
Ng, C. G., Boks, M. P. M., Zainal, N. Z., & de Wit, N. J. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.034 · Cited by 138
Kim, J.-M., Bae, K.-Y., Stewart, R., Jung, B.-O., Kang, H.-J., Kim, S.-W., Shin, I.-S., Hong, Y. J., Kim, J. H., Shin, H.-Y., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09281 · Cited by 71
Self-citationBDNF genotype potentially modifying the association between incident stroke and depression
Kim, J.-M., Stewart, R., Kim, S.-W., Yang, S.-J., Shin, I.-S., Kim, Y.-H., & Yoon, J.-S. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.021 · Cited by 64
Self-citationRelationship between a hopeful attitude and cellular immunity in patients with breast cancer
Kim, S.-W., Kim, S.-Y., Kim, J.-M., Park, M.-H., Yoon, J.-H., Shin, M.-G., Na, H.-S., Bae, K.-Y., Shin, I.-S., & Yoon, J.-S. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.04.002 · Cited by 58
Self-citation
Cited by
Comorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Steffen, A., Nübel, J., Jacobi, F., Bätzing, J., & Holstiege, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02546-8 · Cited by 212
A meta-analysis on heart rate variability biofeedback and depressive symptoms
Pizzoli, S. F. M., Marzorati, C., Gatti, D., Monzani, D., Mazzocco, K., & Pravettoni, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-86149-7 · Cited by 170
Estimating the global treatment rates for depression: a systematic review and meta-analysis
Mekonen, T., Chan, G. C. K., Connor, J. P., Hides, L., & Leung, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.038 · Cited by 137
Jaradat, R., Lahlouh, A., & Mustafa, M. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2019.11.1258 · Cited by 72
Metadata
- Authors
- Kang, H.-J., Kim, S.-Y., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Yoon, J.-S., & Kim, J.-M.
- Venue
- Chonnam Medical Journal
- Published
- 2015
- Volume
- 51
- Issue
- 1
- Pages
- 8
- ISSN
- 0377-9564 (ISSN-L)
- 2233-7385
- 2233-7393
- OpenAlex
- W2074736258
- Cited by
- 226
- References
- 27
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.